Anti-Obesity Medication Market is likely to exhibit CAGR of 30.8%, and estimated to hit worth of USD 73,470.85 Million by year 2032 end | PMR

Polaris Market Research, a leading market research organization, has released a report titled "Anti-Obesity Medication Market: Global Industry Share, Trends, Size, Growth, Opportunity and Forecast 2024-2032." The study delivers a thorough analysis of the industry, including competitor and regional analysis, and highlights the latest advancements in the market.

𝐌𝐚𝐫𝐤𝐞𝐭'𝐬 𝐌𝐚𝐣𝐨𝐫 𝐅𝐚𝐜𝐭𝐬

• The global market was valued at USD 6,574.19 million in 2023 and is expected to grow to USD 73,470.85 million.
• The market is anticipated to expand at a CAGR of 30.8% during the forecast period.
• In 2023, North America is anticipated to dominate the market.

• Europe witnesses the highest growth rate in the market

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.polarismarketresearch.com/industry-analysis/anti-obesity-medication-market/request-for-sample

Drug remedy assists patients in sticking to lifestyle alterations and controlling these feedbacks. Usually, monotherapy causes a loss of 3% to 8% of aggregate body weight from onset, and merger therapy can cause even a profound loss. Additionally, some anti-obesity drugs can offer individualistic health advantages such as reduction in blood pressure, detrimental lipid levels, waist perimeter, insulin aversion, non-alcoholic fatty liver illnesses, probability of prominent cardiovascular events, and advancement of diabetic kidney illnesses.

The growing pervasiveness of obesity and overweight persons globally originating from desk-bound lifestyles and substandard dietary patterns is expected to push growth in the anti-obesity medication market. Prominent industry players are diligently occupied in commodity advancement and looking for market consent to entertain the escalating global population struggling with obesity. Also, the growing pervasiveness of obesity and type II diabetes has prompted several studies by market analysis and vendors to concentrate on advancing drugs capable of inscribing both conditions at the same time.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐨𝐫 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐣𝐨𝐫 𝐠𝐥𝐨𝐛𝐚𝐥 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧𝐜𝐥𝐮𝐝𝐞:
• Boehringer Ingelheim International GmbH
• Currax Pharmaceuticals
• Gelesis
• GlaxoSmithKline plc
• Kintai Therapeutics
• Novartis AG
• Novo Nordisk A/S
• Rhythm Pharmaceuticals, Inc.
• VIVUS LLC

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/buy/3765/2

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤
𝗕𝘆 𝗠𝗲𝗰𝗵𝗮𝗻𝗶𝘀𝗺 𝗼𝗳 𝗔𝗰𝘁𝗶𝗼𝗻:
• Centrally Acting Drugs
• Peripherally Acting Drugs
𝗕𝘆 𝗗𝗶𝘀𝘁𝗿𝗶𝗯𝘂𝘁𝗶𝗼𝗻 𝗖𝗵𝗮𝗻𝗻𝗲𝗹 :
• Hospital Pharmacies
• Retail Pharmacies
• Others

𝐁𝐫𝐨𝐰𝐬𝐞 𝐀𝐝𝐝𝐢𝐭𝐢𝐨𝐧𝐚𝐥 𝐃𝐞𝐭𝐚𝐢𝐥𝐬 : https://www.polarismarketresearch.com/industry-analysis/anti-obesity-medication-market

𝐀𝐧𝐭𝐢-𝐎𝐛𝐞𝐬𝐢𝐭𝐲 𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• In 2023, the peripherally acting anti-obesity drugs segment accounted for the largest revenue share, due to the mechanism's ability to improve nutrient absorption and reduce feelings of hunger.

• In 2023, the retail pharmacies segment emerged as the significant revenue share. These outlets provide convenient access to medications for consumers and are commonly located in easily accessible areas within communities.

• In 2023, the North American region dominated the largest market share due to various factors, such as the high prevalence of obesity and supportive government policies. Additionally, strategic maneuvers like mergers, acquisitions, and partnerships among pharmaceutical giants play a pivotal role in shaping the competitive landscape.

• The global key market players include Boehringer Ingelheim International GmbH, Currax Pharmaceuticals, Gelesis, GlaxoSmithKline plc, Kintai Therapeutics, Novartis AG, Novo Nordisk A/S, Rhythm Pharmaceuticals, Inc., VIVUS LLC.

𝐓𝐨𝐩 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐨𝐟 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://www.polarismarketresearch.com/industry-analysis/patient-monitoring-devices-market
𝗕𝗮𝗿𝗶𝗮𝘁𝗿𝗶𝗰 𝗦𝘂𝗿𝗴𝗲𝗿𝘆 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://www.polarismarketresearch.com/industry-analysis/bariatric-surgery-devices-market
𝗘𝗹𝗲𝗰𝘁𝗿𝗼𝗽𝗵𝘆𝘀𝗶𝗼𝗹𝗼𝗴𝘆 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://www.polarismarketresearch.com/industry-analysis/electrophysiology-devices-market
𝗠𝗮𝗺𝗺𝗼𝗴𝗿𝗮𝗽𝗵𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 : https://www.polarismarketresearch.com/industry-analysis/mammography-market
𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗜𝗺𝗮𝗴𝗶𝗻𝗴 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://www.polarismarketresearch.com/industry-analysis/diagnostic-imaging-services-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.